Table 2.
IFN-γ Methylation Level (%) to Demographic and Clinical Characteristics
Characteristics | Category | IFN-γ | |
---|---|---|---|
Mean ± SE | p | ||
Age (year) | < 30 | 42.9±3.5 | NS |
≥ 30 | 47.4±3.2 | ||
Gender | Female | 58.0±6.7 | 0.045 |
Male | 43.6±2.5 | ||
DI exposed | HDI | 41.7±2.7 | 0.017 |
MDI | 61.1±6.4 | ||
TDI | 50.3±6.4 | ||
Smoking status | Current | 57.5±4.7 | 0.004 |
Never | 41.5±2.6 | ||
Atopy | Negative | 47.5±4.1 | NS |
Positive | 44.0±2.9 | ||
Methacholine PC20 (mg/ml) | < 2 | 52.6±5.3 | 0.035 |
≥ 2 | 49.9±3.8 | ||
≥ 32 | 38.6±3.6 | ||
Duration of DI exposure (month) | < 72 | 44.9±3.5 | NS |
≥ 72 | 45.7±3.3 |
Note. NS, no statistical significant with a p value > 0.05.